Xiidra 5% ophthalmic solution single-use vials Images

Generic Name: lifitegrast

This medication has been identified as Xiidra 5% ophthalmic solution single-use vials. It is supplied by Novartis Pharmaceuticals Corporation.

Xiidra is used in the treatment of Dry Eye Disease and belongs to the drug class ophthalmic anti-inflammatory agents. Xiidra 5% ophthalmic solution single-use vials is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Xiidra

Generic Name

lifitegrast

Strength

5% ophthalmic solution single-use vials

Availability

Prescription only

Drug Class

Ophthalmic anti-inflammatory agents

CSA Schedule

Not a controlled drug

Labeler / Supplier

Novartis Pharmaceuticals Corporation

National Drug Code (NDC)

00078-0911

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer